RAC 1.27% $1.55 race oncology ltd

Just in case anyone is worried about our future royalty...

  1. 145 Posts.
    lightbulb Created with Sketch. 642
    Just in case anyone is worried about our future royalty obligations to CoH scaring off aquirers or putting a major dent in the eventual sale value of RAC.

    Pharma royalty financing has been around for decades, some of the biggest drugs in the world by sales are subject to royalty payments:

    See below examples of funds/companies that buy royalty stakes and their portfolios:
    Royalty Pharma: https://www.royaltypharma.com/our-firm/our-portfolio/
    Healthcare Royalty Partners: https://www.hcrx.com/portfolio/
    DRI Healthcare: https://drihealthcare.com/portfolio/

    Notably, drugs like Keytruda, Eyelea and Imbruvica have been subject to royalty payments
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.